- Fentanyl is a potent synthetic opioid similar to morphine but produces analgesia to a greater extent. It is 50-100 times more potent than morphine. However, exhibits vastly different properties and pharmacokinetics. It is indicated for: preoperative analgesia, general anaesthesia, acute pain
- Fentanyl molecules target a subclass of opioid receptor systems in the body, which are localised in the brain within specialised neuroanatomical structures. It is a mu-selective opioid antagonist. It has the capabilities to activate other opioid system receptors such as the delta and potentially the kappa-receptors. The activation of these receptors produces there analgesic affects. The dopamine neurotransmitter is increased in the reward areas of the brain, which elicits the stereotypical exhilaration and relaxation effects, and is associated with the addiction to the drug
- Side effects of Fentanyl can include: confusion, respiratory depression, drowsiness, nausea, visual disturbance, dyskinesia, hallucinations
- Use caution when using other narcotic medication
- Ensure the patient is monitored for signs of respiratory or CNS depression
- Fentanyl can interact with MAOI anti-depressants with the effects of both medications potentiated.
- Overdose side effects include: respiratory depression, somnolence, coma, skeletal muscle flaccidity, bradycardia, hypotension and death.
- There are a wide range of opioid data not a lot independent of Fentanyl alone. Fentanyl is 50-100 times more potent than morphine and is dependent on the person ingesting it
Pharmacokinetics
- Fentanyl is absorbed rapidly due to its lipophilicity and has an almost immediate onset.
- Bioavailability (amount that enters the venous system) of each route of administration:
- Sublingual tablets: 54% bioavailable
- Transmucosal lozenges: 50% bioavailable
- Buccal tablets: 65% bioavailable
- Sublingual spray: 76% bioavailable
- Nasal spray: 64% bioavailable
- The IV volume of distribution is 4L/kg. The oral volume is 25.4L/kg. In hepatically impaired patients, the IV distribution ranges from 0.8-8L/kg.
- Fentanyl quickly crosses the blood brain barrier and produces analgesia in one to two minutes
- Fentanyl is a strong agonist of opioid receptors with 80-100 times the potency of morphine.
- Fentanyl is metabolised to a number of inactive metabolites. It is 99% N-dealkylated to norfentanyl by cytochrome P450. It can also be amide hydrolysed to despropionylfentanyl or alkyl hydroxylated to hydroxfentanyl which is N-dealkylated to hydroxynorfentanyl
- Within 72 hours, 75% of a dose of fentanyl is excreted in the urine with <7% unchanged, and 9% is excreted in the faeces with <1% unchanged
Pharmacodynamics
- Fentanyl is a synthetic opioid with high lipophilicity which allows it to cross the blood-cerebrospinal fluid barrier more rapidly. It is oxidised by hepatic microsomal cytochrome P450 into norfentanyl, an inactive metabolite that is excreted through the renal system
- Fentanyl has an elimination half-life of 4 hours with a shorter duration of action of 30-40 minutes
- Fentanyl crosses the blood brain barrier and produces analgesia within one to two minutes. Serum levels decline rapidly from peak concentrations because of extensive tissue uptake. The brain concentration of fentanyl falls in conjunction with the serum level. Duration of action is 30-40 minutes. In high doses can be several hours due to the release of the bound drug from tissue stores
Clinical Resources Website
St John Ambulance Western Australia Ltd (ABN 55 028 468 715) (St John WA) operates ambulance and other pre-hospital clinical services. St John WA’s Clinical Resources, including its Clinical Practice Guidelines (Clinical Resources), are intended for use by credentialed St John WA staff and volunteers when providing clinical care to patients for or on behalf of St John WA, within the St John WA Clinical Governance Framework, and only to the extent of the clinician’s authority to practice.
Other users – Terms of Use
The content of the St John WA Clinical Resources is provided for information purposes only and is not intended to serve as health, medical or treatment advice. Any user of this website agrees to be bound by these Terms of Use in their use of the Clinical Resources.
St John WA does not represent or warrant (whether express, implied, statutory, or otherwise) that the content of the Clinical Resources is accurate, reliable, up-to-date, complete or that the information contained is suitable for your needs or for any particular purpose. You are responsible for assessing whether the information is accurate, reliable, up-to-date, authentic, relevant, or complete and where appropriate, seek independent professional advice.
St John WA expressly prohibits use of these Clinical Resources to guide clinical care of patients by organisations external to St John WA, except where these organisations have been directly engaged by St John WA to provide services. Any use of the Clinical Resources, with St John WA approval, must attribute St John WA as the creator of the Clinical Resources and include the copyright notice and (where reasonably practicable) provide a URL/hyperlink to the St John WA Clinical Resources website.
No permission or licence is granted to reproduce, make commercial use of, adapt, modify or create derivative works from these Clinical Resources. For permissions beyond the scope of these Terms of Use, including a commercial licence, please contact medservices@stjohnambulance.com.au
Where links are provided to resources on external websites, St John WA:
- Gives no assurances about the quality, accuracy or relevance of material on any linked site;
- Accepts no legal responsibility regarding the accuracy and reliability of external material; and
- Does not endorse any material, associated organisation, product or service on other sites.
Your use of any external website is governed by the terms of that website, including any authorisation, requirement or licence for use of the material on that website.
To the maximum extent permitted by law, St John WA excludes liability (including liability in negligence) for any direct, special, indirect, incidental, consequential, punitive, exemplary or other loss, cost, damage or expense arising out of, or in connection with, use or reliance on the Clinical Resources (including without limitation any interference with or damage to a user’s computer, device, software or data occurring in connection with such use).
Cookies
Please read this cookie policy carefully before using Clinical Resources from St John WA.
The cookies used on this site are small and completely anonymous pieces of information and are stored on your computer or mobile device. The data that the cookies contain identify your user preferences (such as your preferred text size, scope / skill level preference and Colour Assist mode, among other user settings) so that they can be recalled the next time that you visit a page within Clinical Resources. These cookies are necessary to offer you the best and most efficient possible experience when accessing and navigating through our website and using its features. These cookies do not collect or send analytical information back to St John WA.
Clinical Resources does integrate with Google Analytics and any cookies associated with this service enable us (and third-party services) to collect aggregated data for statistical purposes on how our visitors use this website. These cookies do not contain personal information such as names and email addresses and are used to help us improve your user experience of the website.
If you want to restrict or block the cookies that are set by our website, you can do so through your browser setting. Alternatively, you can visit www.internetcookies.com, which contains comprehensive information on how to do this on a wide variety of browsers and devices. You will find general information about cookies and details on how to delete cookies from your device. If you have any questions about this policy or our use of cookies, please contact us.